Pharm
Tacrolimus Ointment
search
Tacrolimus Ointment
, Protopic, Elidel, Pimecrolimus
Indications
Severe refractory
Atopic Dermatitis
Pharmacokinetics
Normal topical use causes <5 ng/ml serum concentration
Greater absorption in severely damaged skin
Factors increasing serum concentrations
Higher doses or greater surface area of application
Inflamed skin
Mechanism
Macrolide
with similar activity to
Cyclosporine
Specifically binds T Cell receptors
Inhibits
Cytokine
production
Inhibits IgE sensitivity
Precautions
Increased risk of
Skin Malignancy
and
Lymphoma
FDA black box warning has been added
Do not use for extended periods of time
Use only in refractory
Eczema
Preparations
Pimecrolimus (Elidel)
Tacrolimus
(Protopic)
Dosing
Tracolimus
Children over age 2 years: Apply 0.03% ointment bid
Adults: Apply 0.03% or 0.1% ointment bid
Adverse Effects
Local irritation (transient <1 week)
Burning
Erythema
Pruritus
Less common adverse effects
Skin Tingling
Acne
Hyperesthesia
Alcohol
intolerance
Immunosuppression
related adverse effects
Varicella zoster increased
Incidence
Eczema
herpeticum
Increased malignancy risk in mice (see precautions)
Skin Cancer
Lymphoma
Precautions
Protect treated areas from direct sunlight
Systemic
Tacrolimus
associated with
Skin Cancer
Non-melanoma
Skin Cancer
Advantages
Very effective in refractory atopic cases
Unlike
Corticosteroid
s, does not cause skin atrophy
May be useful on face and neck
Disadvantages
Expensive (costs per Red Book)
Tacrolimus Ointment (0.03 or 0.1%): $60 per 30 grams
Risk of malignancy (see prcautions)
Skin Cancer
Lymphoma
References
Bekersky (2001) J Am Acad Dermatol 44:S17 [PubMed]
Hanifin (2001) J Am Acad Dermatol 44:S28 [PubMed]
Kang (2001) J Am Acad Dermatol 44:S58 [PubMed]
Paller (2001) J Am Acad Dermatol 44:S47 [PubMed]
Ruzicka (1997) N Engl J Med 337:816 [PubMed]
(2001) Med Lett Drugs Ther 43(1102):33-34 [PubMed]
Type your search phrase here